Chung-Wah Wu
Overview
Explore the profile of Chung-Wah Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu C, Jao-Yiu Sung J
Chin Clin Oncol
. 2015 Apr;
2(1):8.
PMID: 25841449
Colorectal cancer (CRC) is the third commonest cancer worldwide. As many CRC patients were identified at advanced stages, screening asymptomatic individuals has substantial clinical benefit. Most CRC arises through recognizable...
2.
Dong Y, Zhao J, Wu C, Zhang L, Liu X, Kang W, et al.
Mol Cancer Res
. 2013 Jun;
11(9):1051-60.
PMID: 23723074
Unlabelled: Dysregulated microRNA (miRNA) expression was profiled through a miRNA array comparison between human colorectal cancer tumors and their adjacent normal tissues. Specifically, using laser capture micro-dissection, miR-133a was shown...
3.
Wu C, Dong Y, Liang Q, He X, Ng S, Chan F, et al.
PLoS One
. 2013 Feb;
8(2):e57036.
PMID: 23437304
Background: miR-18a is one of the most up-regulated miRNAs in colorectal cancers (CRC) based on miRNA profiling. In this study, we examined the functional significance of miR-18a in CRC. Methods:...
4.
Wu C, Farrell G, Yu J
J Gastroenterol Hepatol
. 2012 Jun;
27(11):1665-9.
PMID: 22742931
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Major risk factors of HCC include infection with hepatitis B or C viruses, alcohol and non-alcoholic fatty liver disease. HCC...
5.
6.
Yu J, Shen B, Chu E, Teoh N, Cheung K, Wu C, et al.
Hepatology
. 2010 Jun;
51(6):2008-19.
PMID: 20512989
Unlabelled: Although peroxisome proliferator-activated receptor gamma (PPARgamma) agonist have been shown to inhibit hepatocellular carcinoma (HCC) development, the role of PPARgamma in hepatocarcinogenesis remains unclear. We investigated the therapeutic efficacy...
7.
Yu J, Zhang S, Chu E, Go M, Lau R, Zhao J, et al.
Int J Biochem Cell Biol
. 2010 Feb;
42(6):948-57.
PMID: 20156580
Nonalcoholic steatohepatitis with fibrosis is a more severe form of nonalcoholic fatty liver disease, one of the most common liver diseases. We have previously shown that peroxisome proliferator-activated receptors gamma...